Nevena Damjanov, MD of University of Pennsylvania discusses how regorafenib will be incorporated into clinical practice at 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Advertisement
[the_ad id="32629"]